{"brief_title": "A Study for the Treatment of Painful Diabetic Neuropathy", "brief_summary": "The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.", "detailed_description": "The protocol will assess the efficacy and safety of duloxetine. It will also look at how duloxetine affects quality of life.", "condition": ["Diabetic Neuropathy, Painful"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Duloxetine hydrochloride", "placebo"], "criteria": "Inclusion Criteria: - Male or female outpatients at least 18 years of age. - Patients with pain due to diabetic neuropathy in both legs. - Females must not be pregnant or plan to become pregnant during the study. - Stable Glycemic control. - Average mean pain severity score of at least 4.0 as assessed by completion of a daily diary. Exclusion Criteria: - You are related to or work for the physician conducting the study or are employed by Eli Lilly and Company. - You have a severe or serious medical condition that causes you to be hospitalized often; or you have had a kidney transplant or are on current dialysis. - You have participated in a study for an investigational drug within the last 30 days. - You have a history of major depressive disorder, generalized anxiety disorder, or alcohol or eating disorders. - You have a past medical history or diagnosis of mania, bipolar disorder, or psychosis.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "diabetic neuropathy", "mesh_term": ["Peripheral Nervous System Diseases", "Pain", "Diabetic Neuropathies", "Duloxetine Hydrochloride"], "id": "NCT00058968"}